Alexza Initiates AZ-007 Clinical Trial

Armen Hareyan's picture
Advertisement

Alexza Pharmaceuticals has initiated a Phase 1 clinical trial with AZ-007 (Staccato zaleplon). AZ-007 is an inhalation product candidate being developed for the treatment of insomnia patients who have difficulty falling asleep, including patients who awake in the middle of the night and have difficulty falling back asleep. This is the first clinical trial of AZ-007 being conducted under an IND filed

Advertisement